Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,693.20
(
-0.06%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.29
(
-2.80%
)
Bitcoin
69,435.14
(
-2.71%
)
News Focus
News Focus
Post# of 828667
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 91
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: sukus post# 595126

Monday, 05/22/2023 12:12:58 PM

Monday, May 22, 2023 12:12:58 PM

Post# of 828667

Did shorts know the significance of this? I guess they are too busy shorting nowadays. They shorted a lot of companies lately.


I would think most shorts know that Yervoy was first approved on a Phase 1.

Knowing why some drugs are approved on early trial data is important. Just like knowing why other data might not be worthy of an approval.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News